Equities

abrdn Life Sciences Investors

HQL:NYQ

abrdn Life Sciences Investors

Actions
FinancialsClosed End Investments
  • Price (USD)13.68
  • Today's Change0.025 / 0.18%
  • Shares traded39.94k
  • 1 Year change+0.48%
  • Beta0.7111
Data delayed at least 15 minutes, as of Mar 28 2024 17:29 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • On date 09 Feb 2024, HQL:NYQ announced a new dividend of amount 0.39 payable on date 09 Feb 2024
  • HQL:NYQ price rises above 15-day moving average to 13.62 at 12:42 BST

Key statistics

As of last trade abrdn Life Sciences Investors (HQL:NYQ) traded at 13.68, -4.84% below its 52-week high of 14.37, set on Jan 12, 2024.
52-week range
Today
11.34Oct 27 202314.37Jan 12 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open13.66
High13.71
Low13.62
Bid13.67
Offer13.68
Previous close13.65
Average volume69.49k
Shares outstanding26.21m
Free float25.63m
P/E (TTM)15.67
Market cap357.79m USD
EPS (TTM)0.8712
USD
Annual div (ADY)1.33
USD
Annual div yield (ADY)9.74%
Div ex-dateFeb 21 2024
Div pay-dateMar 28 2024
Data delayed at least 15 minutes, as of Mar 28 2024 17:29 BST.
More ▼
All data shown on this page, unless noted otherwise is Data Source and Copyright: Morningstar, Inc. 2024
All Rights reserved
© 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.